Why the study?
Do common genetic variants in lipid transport loci relate to plasma lipid levels and premature coronary artery disease in Spanish men?
Do common genetic variants in lipid transport loci relate to plasma lipid levels and premature coronary artery disease in Spanish men?
In northern Spanish men, specific genetic variants in the apolipoprotein B signal peptide region are associated with premature coronary artery disease, while other variants relate to plasma lipid levels.
Answers are grounded in this paper and cite their sources.
Apolipoprotein B signal peptide variants associate with premature arterial disease in Spanish men; hypothesis-generating, should not yet change practice.
Fifteen common polymorphic variants at six loci (apolipoproteins AI, B, CIII and E, hepatic lipase and lipoprotein lipase) involved in plasma lipid transport have been studied in 210 northern Spanish men, of whom 98 had proven coronary artery disease. The other 112 men were clinically free from coronary artery disease and acted as controls. The genotypes were investigated for relationships with plasma lipid and lipoprotein levels, as well as for the presence of coronary artery disease. As expected, the mean levels of plasma triacylglycerols (triglycerides) and lipoprotein (a) and the number of smokers were significantly higher in the disease group, and high-density lipoprotein (HDL)-cholesterol was significantly lower. Surprisingly, plasma cholesterol and low-density lipoprotein cholesterol were not different between the two groups. With regard to the common mutations, plasma triacylglycerol levels were related to the HindIII variants of lipoprotein lipase (P<0.05), to the apolipoprotein CIII variant (C3175G in exon 4) and to the apolipoprotein AI XmnI polymorphisms (P<0.05 and P<0.02 respectively). The apolipoprotein E variants were related to plasma cholesterol (P<0.05), HDL-cholesterol (P<0.02), plasma triacylglycerols (P<0.05) and the triacylglycerol/HDL ratio (P<0.01). Only the three-codon insertion/deletion variants of the apolipoprotein B signal peptide region discriminated between the two groups with or without arterial disease (P=0.02). The possible functional effects of these common mutations are discussed.
No takes yet. Share an insight, caveat, or question.
Masana et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: